Cargando…
Administration of COVID-19 vaccines in immunocompromised patients
Since the beginning of vaccination programs against COVID-19 in different countries, several populations such as patients with specific immunological conditions have been considered as the priorities for immunization. In this regard, patients with autoimmune diseases or those receiving immunosuppres...
Autores principales: | Negahdaripour, Manica, Shafiekhani, Mojtaba, Moezzi, Seyed Mohammad Iman, Amiri, Sogand, Rasekh, Shiva, Bagheri, Ashkan, Mosaddeghi, Pouria, Vazin, Afsaneh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316069/ https://www.ncbi.nlm.nih.gov/pubmed/34352567 http://dx.doi.org/10.1016/j.intimp.2021.108021 |
Ejemplares similares
-
Interferon-inducer antivirals: Potential candidates to combat COVID-19
por: Bagheri, Ashkan, et al.
Publicado: (2021) -
Harnessing the non-specific immunogenic effects of available vaccines to combat COVID-19
por: Mosaddeghi, Pouria, et al.
Publicado: (2020) -
Deep survey for designing a vaccine against SARS-CoV-2 and its new mutations
por: Vakili, Bahareh, et al.
Publicado: (2021) -
Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen
por: Mirjalili, Mahtabalsadat, et al.
Publicado: (2020) -
Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial
por: Shafiekhani, Mojtaba, et al.
Publicado: (2020)